Infectious Diseases

Part Time Faculty

Pierre Dejace, MD
Associate Professor of Clinical Medicine

Biography
Dr Dejace received his medical degree from the Free University of Brussels, Belgium in 1975. In 1976, he received a degree of Tropical Medicine from the Tropical Medicine Institute in Antwerp, Belgium.

Beginning in 1976, Dr. Dejace practiced medicine for 2 years in Rwanda before getting training in Internal Medicine at Baystate Medical Center in Springfield, Massachusettts, a Tufts Medical School affiliate. In 1984, Dr. Dejace completed an Infectious Diseases fellowship at Brown University Affiliated Hospitals in Providence, Rhode Island.

Dr Dejace joined the Tulane University School of Medicine faculty as an Assistant Professor of Medicine in the Department of Medicine, Section of Infectious Diseases in 1988. Dr. Dejace is also chief of the Infectious Diseases Program at the Southeast Louisiana Veterans Health Care Systems (VA).

Dr. Dejace’s research interests are: 1)Tropical Medicine 2)HIV Infections, and 3) Infections in cancer patients. 

Selected Publications
Dejace P, Zinner SH. Yeast vaginitis. In Feldman Y (ed): Textbook of Sexually Transmitted Diseases, New York, Churchill Livingstone, 1986.

Dejace P, Klastersky JA. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. American Journal of Medicine 1986; 80:29-39.

Dejace P, Klastersky J. Measurement of bactericidal activity in body fluids as a clinical research procedure. European Journal of Clinical Microbiology 1986; 5:58-60.

Dejace P and Klastersky J. Emergence of resistance as a consequence of antimicrobial prophylaxis in immuno-compromised patients. Scandinavian Journal of Infectious Diseases 1986; 49:165-171

Dejace P. Diagnosis and surveillance of infections in neutropenic cancer patients. European Journal of Cancer and Clinical Oncology 1986; 22:1135-1138.

Richard V, Meunier F, van der Auwera P, Dejace P, Daneau D, Klastersky J. Pneumococcal bacteremia in cancer patients. European Journal of Epidemiology 1988; 4(2):242-245.

Dejace P. Que faire aprs le traitement infectieux empirique en attendant la remonte de la leucocytose? Ranimation et Medecine d’urgence, Paris, Masson 1988.

Dejace P, Klastersky J. Infections in cancer patients. In Veronesi P (ed): Surgical Oncology, Berlin, Springer Verlag 1989.

Love G, Dejace P, Acremant C. Cervicofacial nocardiosis caused by Nocardia brasiliensis in an adult. Clinical Infectious Diseases, November 1994; 17(5):933-934.

Witzig RS, Fazal BA, Mera RM, Mushatt DM, Dejace P, Greer DL, Hyslop NE. Clinical manifestations and Implications of coinfection with Mycobacterium kansasii and Human Immunodeficiency Virus type 1. Clinical Infectious Diseases July 1995; 21(9):752-806.

Akula SK, Rege AB, Dreisbach AW, Dejace P, Lertora JJ. Valproic Acid increases cerebro-spinal fluid level of zidovudine in a patient with AIDS. The American Journal of Medical Sciences 1977; 313:244-246.

Donta ST, Engel C, Collins JF, Baseman JB, Dejace P. Benefits and harms of doxycycline treatment for Gulf War Veterans Illness: a randomized, double-blind, placebo-controlled trial. Annals of internal Medicine 2004; 141:85-94.

Ruhe J, Menon A, Mushatt D, Dejace P, Hasbun R. Non-epidermidis coagulase-negative staphylococcal bacteremia:clinical predictors of true bacteremia: European Journal of Clinical Microbiology and Infectious Diseases 2004; 23(6):495-498.